Información del artículo
El Texto completo está disponible en PDF
Bibliogrífia
[1.]
D.K. Shay, R.C. Holman, R.D. Newman, L.L. Liu, J.W. Stout, L.J. Anderson.
Bronchiolitis-associated hospitalizations among U.S. children, 1980–1996.
JAMA, 282 (1999), pp. 1440-1446
[2.]
L.L. Kimpen Jan.
Management of respiratory syncytial virus infection.
Curr Opin Infect Dis, 14 (2001), pp. 323-328
[3.]
R.B. Wright, W.J. Pomerantz, J.W. Luria.
New approaches to respiratory infections in children. Bronchiolitis and croup.
Emerg Med Clin North Am, 20 (2002), pp. 93-114
[4.]
N. Sigurs, R. Bjarnason, F. Sigurbergsson, B. Kjellman.
Respiratory Syncytial Virus Bronchiolitis in Infancy is an important risk factor for asthma and allergy at age 7.
Am J Respir Crit Care Med, 161 (2000), pp. 1501-1507
[5.]
C.E. Long, J.T. McBride, C.B. Hall.
Sequelae of respiratory syncytial virus infections: A role for intervention studies.
Am J Respir Crit Care Med, 151 (1995), pp. 1678-1681
[6.]
M. Korppi, L. Kuikka, T. Reijonen, K. Remes, K. Juntunen-Backman, K. Launiala.
Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study.
Arch Pediatr Adolesc Med, 148 (1994), pp. 1079-1084
[7.]
J.L. Kimpen, E.A. Simoes.
Respiratory Syncytial Virus and Reactive Airway Disease.
Am J Respir Crit Care Med, 163 (2001), pp. S1
[8.]
G. Folkerts, W.W. Busse, F.P. Nijkamp, R. Sorkness, J.E. Gern.
Virus-induced airway hyperresponsiveness and asthma.
Am J Resp Crit Care Med, 157 (1998), pp. 1708-1720
[9.]
F.D. Martinez, A.L. Wright, L.M. Taussig, C.J. Holberg, M. Halonen, J.W. Morgan.
Asthma and wheezing in the first six years of life.
N Engl J Med, 332 (1995), pp. 133-138
[10.]
M. Erikson, R. Bennet, A. Nilsson.
Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy.
Pediatr Allergy Immunol, 11 (2000), pp. 193-197
[11.]
D. González Caballero, E. González Pérez-Yarza.
Bronquiolitis aguda: bases para un protocolo racional.
An Esp Pediatr, 55 (2001), pp. 355-364
[12.]
F.D. Martinez.
Development of wheezing disorders and asthma in preschool children.
Pediatrics, 2 (2002), pp. 362-367
[13.]
N.W. Luckas.
Role of chemokines in the pathogenesis of asthma.
Nature Immunol, 1 (2001), pp. 108-116
[14.]
R.C. Welliver.
The role of RSV IgE in recurrent wheezing and asthma.
RSV and Asthma: Is There a link?, pp. 21-27
[15.]
R.T. Stein, D. Sherrill, W.J. Morgan, C.J. Holberg, M. Halonen, L.M. Taussig, et al.
Respiratory Syncytial Virus in early life and risk of wheeze and allergy by age 13 years.
Lancet, 354 (1999), pp. 541-545
[16.]
R. Medzhitov, C. Janeway.
Innate Immunity.
N Engl J Med, 3 (2000), pp. 338-344
[17.]
P. Delves, I.M. Roitt.
The Immune System.
N Engl J Med, 343 (2000), pp. 37-49
[18.]
R.P. Garofalo, H. Haeberle.
Epithelial regulation of innate immunity to respiratory syncytial virus.
Am J Respir Cell Mol Biol, 23 (2000), pp. 581-585
[19.]
H.S. Jafri.
Role of chemokines in respiratory syncytial virus disease.
Pediatr Infect Dis J, 21 (2002), pp. 454-456
[20.]
R.A. Tripp, D. Moore, A. Barskey IV, L. Jones, C. Moscatiello, H. Keyserling, et al.
Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T Helper-1 and T Helper-2 cytokines and CC Chemokine messenger RNA.
J Infect Dis, 185 (2002), pp. 1388-1394
[21.]
P. Sheeran, H. Jafri, C. Carubelli, J. Saavedra, C. Johnson, K. Krisher, et al.
Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease.
Ped Infect Dis J, 18 (1999), pp. 115-122
[22.]
H.S. Jafri, P. Sheeran, C. Carubelli, J. Saavedra, P.J. Sanchez, O. Ramilo.
Systemic IL-6, IL-8, and RANTES response in children with respiratory syncytial virus disease.
Pediatr Res, 45 (1999), pp. 955
[23.]
American Academy of Pediatrics.
Committee of Infectious Diseases. Reassessment of indications for ribavirin therapy in respiratory syncytial virus infections.
Pediatr, 97 (1996), pp. 137-140
[24.]
R. Malley, J. De Vicenzo, O. Ramilo, P.H. Dennehy, H.C. Meissner, W.C. Gruber, et al.
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
J Infect Dis, 178 (1998), pp. 1555-1561
[25.]
D. Edell, V. Koshoo, G. Ross, K. Salter.
Early ribavirin treatment of bronchiolitis: Effect on long-term respiratory morbidity. Chest.
In press, (2002),
[26.]
T.M. Reijonen, A. Kotaniemi-Syrjanen, K. Korhonen, M. Korppi.
Predictors of asthma three years after hospital admission for wheezing in infancy.
Pediatrics, 106 (2000), pp. 1406-1412
[27.]
T. Reijonen, M. Korppi, L. Kuikka, K. Remes.
Anti-inflammatory therapy reduces wheezing after bronchiolitis.
Arch Pediatr Adolesc Med, 150 (1996), pp. 512-517
[28.]
M. Callén, P. Aizpurua, I. Ozcoidi, L. Mancisidor, C. Guedea, E. Busselo, et al.
Glucocorticoides inhalados y sibilancias posbronquiolitis.
An Esp Pediatr, 52 (2000), pp. 351-355
[29.]
S.C. Buckingham, H.S. Hafri, A.J. Bush, C.M. Carubelli, P. Sheeran, R.D. Hardy, et al.
A randomized double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: Effects on RSV quantity and clinical outcome.
J Infect Dis, 185 (2002), pp. 1222-1228
[30.]
J.T. McBride.
Pulmonary function changes in children after respiratory syncytial virus infection in infancy.
J Pediatr, 135 (1999), pp. 28-32
[31.]
Á García-Marcos, L. lvarez, J.J. Guillén Pérez.
Infección y asma. ¿Cuál es su relación?.
An Esp Pediatr, 56 (2002), pp. 31-35
Copyright © 2002. Asociación Española de Pediatría
